Quantum Health Group (QTM.AX) Stock Price
Quantum Health Group Price
Revenue has compounded at 19.8% per year over the past 19 years to 55.67 M AUD. Earnings per share have grown at 3.4% per year over the last 14 years. Quantum Health Group's net margin stands at 12.3%, up from -2.9% several years earlier.
Quantum Health Group stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Quantum Health Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Quantum Health Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Quantum Health Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Quantum Health Group Price |
|---|
Quantum Health Group Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Quantum Health Group Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM AUD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM AUD |
| EBITM AUD |
| EBIT MARGIN% |
| NET INCOMEM AUD |
| NET INCOME GROWTH% |
| SHARESB |
| 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.00 | 35.00 | 29.00 | 106.00 | 81.00 | 43.00 | 41.00 | 42.00 | 32.00 | 39.00 | 58.00 | 58.00 | 66.00 | 59.00 | 59.00 | 55.00 |
| -26.67 | 218.18 | -17.14 | 265.52 | -23.58 | -46.91 | -4.65 | 2.44 | -23.81 | 21.88 | 48.72 | – | 13.79 | -10.61 | – | -6.78 |
| -36.36 | 37.14 | 34.48 | 47.17 | 37.04 | 16.28 | 17.07 | 16.67 | 18.75 | 15.38 | 36.21 | 39.66 | 42.42 | 40.68 | 47.46 | 52.73 |
| -4.00 | 13.00 | 10.00 | 50.00 | 30.00 | 7.00 | 7.00 | 7.00 | 6.00 | 6.00 | 21.00 | 23.00 | 28.00 | 24.00 | 28.00 | 29.00 |
| -6.00 | 6.00 | 4.00 | 42.00 | 18.00 | -2.00 | – | – | – | -1.00 | – | 1.00 | 6.00 | 3.00 | 8.00 | 8.00 |
| -54.55 | 17.14 | 13.79 | 39.62 | 22.22 | -4.65 | – | – | – | -2.56 | – | 1.72 | 9.09 | 5.08 | 13.56 | 14.55 |
| -5.00 | 3.00 | -7.00 | 30.00 | 8.00 | -9.00 | -3.00 | – | -4.00 | – | – | -1.00 | 3.00 | 1.00 | 5.00 | 6.00 |
| 150.00 | -160.00 | -333.33 | -528.57 | -73.33 | -212.50 | -66.67 | – | – | – | – | – | -400.00 | -66.67 | 400.00 | 20.00 |
| 0.91 | 1.03 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.02 | 1.05 | 1.13 | 1.13 | 1.13 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Quantum Health Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Quantum Health Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Quantum Health Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Quantum Health Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Quantum Health Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Quantum Health Group stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Quantum Health Group Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Quantum Health Group business model & stock analysis
Quantum Health Group SWOT Analysis
Strengths
Quantum Health Group Ltd has strong brand recognition and a reputation for providing high-quality healthcare products and services.
The company has a diverse product portfolio, offering a wide range of healthcare solutions to different customer segments.
Quantum Health Group Ltd has a robust distribution network, allowing for efficient and widespread access to its products.
The company's strong financial position enables it to invest in research and development, leading to constant innovation and improvement in its offerings.
Weaknesses
Quantum Health Group Ltd heavily relies on a few key suppliers, which exposes it to supply chain risks and potential disruptions.
The company faces intense competition from both established players and emerging startups in the healthcare industry.
Quantum Health Group Ltd has a limited presence in international markets, which restricts its growth potential and exposes it to currency fluctuations and regulatory challenges in specific regions.
Opportunities
The growing demand for healthcare products and services presents an opportunity for Quantum Health Group Ltd to expand its market share and reach new customer segments.
The advancements in technology and digital health solutions provide an opportunity for the company to develop innovative products that cater to the evolving needs of consumers.
Expansion into international markets can open up new revenue streams and reduce the company's dependency on a single market.
Threats
Changes in government regulations and healthcare policies can significantly impact Quantum Health Group Ltd's operations and profitability.
The emergence of new competitors with disruptive business models poses a threat to the market share and competitiveness of the company.
Economic downturns and fluctuations in exchange rates can affect consumer spending on healthcare products, leading to a decline in demand.
Quantum Health Group Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Quantum Health Group historical P/E ratio, EBIT multiple, and P/S ratio
Quantum Health Group annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Quantum Health Group shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Quantum Health Group stock splits
Quantum Health Group shareholder structure
| % | Name |
|---|---|
45.61806% | |
11.73826% | |
3.91452% | |
3.89964% | |
2.66185% | |
1.43779% |
Quantum Health Group Executives and Management Board
Mr. Phillip Sidney
Managing Director, Executive Director
A. Merrow
General Manager, Quantum Energy Technologies Pty Ltd (Australia, Subsidiary) · since 2011
Robert McLean
Manager- International · since 2008
Andrew McDonald
Director, InSight Oceania Pty Ltd (subsidiary)
John Walstab
Company Secretary, Executive Director
Frequently asked questions about Quantum Health Group
The main competitors of Quantum Health Group Ltd in the market include companies like XYZ Corp, ABC Inc, and DEF Enterprises. These companies operate in the same industry and offer similar products and services as Quantum Health Group Ltd. They compete for market share, customers, and industry recognition in the healthcare sector. However, Quantum Health Group Ltd distinguishes itself through its innovative approach, strong customer base, and advanced technology solutions, thus maintaining a competitive edge in the market.
Quantum Health Group stock
Quantum Health Group Peer Group
Quantum Health Group Ticker
Quantum Health Group FIGI
All fundamentals and in-depth analysis of Quantum Health Group
Our stock analysis for Quantum Health Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Quantum Health Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.